Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
File(s)Dao_et_al_accepted_updated_2.pdf (2.22 MB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Objective Individuals with obesity and type 2 diabetes differ from lean and healthy individuals in their abundance of certain gut microbial species and microbial gene richness. Abundance of Akkermansia muciniphila, a mucin-degrading bacterium, has been inversely associated with body fat mass and glucose intolerance in mice, but more evidence is needed in humans. The impact of diet and weight loss on this bacterial species is unknown. Our objective was to evaluate the association between faecal A. muciniphila abundance, faecal microbiome gene richness, diet, host characteristics, and their changes after calorie restriction (CR).
Design The intervention consisted of a 6-week CR period followed by a 6-week weight stabilisation diet in overweight and obese adults (N=49, including 41 women). Faecal A. muciniphila abundance, faecal microbial gene richness, diet and bioclinical parameters were measured at baseline and after CR and weight stabilisation.
Results At baseline A. muciniphila was inversely related to fasting glucose, waist-to-hip ratio and subcutaneous adipocyte diameter. Subjects with higher gene richness and A. muciniphila abundance exhibited the healthiest metabolic status, particularly in fasting plasma glucose, plasma triglycerides and body fat distribution. Individuals with higher baseline A. muciniphila displayed greater improvement in insulin sensitivity markers and other clinical parameters after CR. These participants also experienced a reduction in A. muciniphila abundance, but it remained significantly higher than in individuals with lower baseline abundance. A. muciniphila was associated with microbial species known to be related to health.
Conclusions A. muciniphila is associated with a healthier metabolic status and better clinical outcomes after CR in overweight/obese adults. The interaction between gut microbiota ecology and A. muciniphila warrants further investigation.
Design The intervention consisted of a 6-week CR period followed by a 6-week weight stabilisation diet in overweight and obese adults (N=49, including 41 women). Faecal A. muciniphila abundance, faecal microbial gene richness, diet and bioclinical parameters were measured at baseline and after CR and weight stabilisation.
Results At baseline A. muciniphila was inversely related to fasting glucose, waist-to-hip ratio and subcutaneous adipocyte diameter. Subjects with higher gene richness and A. muciniphila abundance exhibited the healthiest metabolic status, particularly in fasting plasma glucose, plasma triglycerides and body fat distribution. Individuals with higher baseline A. muciniphila displayed greater improvement in insulin sensitivity markers and other clinical parameters after CR. These participants also experienced a reduction in A. muciniphila abundance, but it remained significantly higher than in individuals with lower baseline abundance. A. muciniphila was associated with microbial species known to be related to health.
Conclusions A. muciniphila is associated with a healthier metabolic status and better clinical outcomes after CR in overweight/obese adults. The interaction between gut microbiota ecology and A. muciniphila warrants further investigation.
Date Issued
2016-02-12
Date Acceptance
2015-05-01
Citation
Gut, 2016, 65 (3), pp.426-436
ISSN
1468-3288
Publisher
BMJ Publishing Group
Start Page
426
End Page
436
Journal / Book Title
Gut
Volume
65
Issue
3
Copyright Statement
© The Author(s) 2015. The published version is available here: http://doi.org/10.1136/gutjnl-2014-308778
Sponsor
Commission of the European Communities
Grant Number
305312
Subjects
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
INSULIN-RESISTANCE
GASTRIC BYPASS
BARIATRIC SURGERY
ADIPOCYTE SIZE
GLUCOSE
HOST
SENSITIVITY
METAGENOME
POPULATION
EXPRESSION
GLUCOSE METABOLISM
INTESTINAL BACTERIA
OBESITY
Adult
Aged
Biomarkers
Blood Glucose
Diet, Reducing
Feces
Female
Gastrointestinal Microbiome
Humans
Insulin Resistance
Male
Middle Aged
Obesity
Treatment Outcome
Triglycerides
Verrucomicrobia
MICRO-Obes Consortium
Feces
Humans
Insulin Resistance
Obesity
Blood Glucose
Triglycerides
Treatment Outcome
Diet, Reducing
Adult
Aged
Middle Aged
Female
Male
Verrucomicrobia
Biomarkers
Gastrointestinal Microbiome
Gastroenterology & Hepatology
1103 Clinical Sciences
1114 Paediatrics and Reproductive Medicine
Publication Status
Published
Date Publish Online
2015-06-22